Clinical and Histological Predictors of Renal Survival in Patients with Biopsy-Proven Diabetic Nephropathy

被引:3
|
作者
Zhou, Ting [1 ]
Wang, Yiyun [2 ]
Shen, Li [3 ]
Li, Xiaomei [1 ]
Jiao, Qiong [1 ]
Li, Ze [1 ]
Jia, Junjie [1 ]
He, Li [1 ]
Zhang, Qunzi [1 ]
Wang, Niansong [1 ]
Fan, Ying [1 ]
机构
[1] Shanghai Jiao Tong Univ, Dept Nephrol, Affiliated Peoples Hosp 6, Shanghai, Peoples R China
[2] Shanghai United Family Hosp, Dept Emergency, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Clin Res Unit, Affiliated Peoples Hosp 6, Shanghai, Peoples R China
关键词
Diabetic nephropathy; Clinical characteristic; Pathology; Renal biopsy; Prediction; GLOMERULAR-FILTRATION-RATE; PRACTICE GUIDELINE; KIDNEY-DISEASE; OUTCOMES; ALBUMINURIA; MANAGEMENT; PROGNOSIS;
D O I
10.1159/000518222
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Clinical indicators or pathological features alone cannot reliably predict renal survival in patients with biopsy-confirmed diabetic nephropathy (DN). Therefore, this analysis sought to develop and validate a predictive model incorporating both clinical and pathological markers to predict renal outcomes in patients with biopsy-confirmed DN. Methods: A predictive nomogram was developed based upon data pertaining to 194 patients with biopsy-confirmed DN. The prognostic relevance of individual clinicopathological variables was assessed through univariate and multivariate Cox regression analyses. A prognostic nomogram was then developed and validated based upon concordance (C)-index values and calibration curves. Internal validation was conducted through bootstrap resampling, while the clinical utility of this model was assessed via a decision curve analysis (DCA) approach. Results: Nephrotic-range 24-h proteinuria, late-stage CKD, glomerular classification III-IV, and IFTA score 2-3 were all identified as independent predictors of poor renal outcomes in DN patients and were incorporated into our final nomogram. Calibration curves revealed good agreement between predicted and actual 3- and 5-year renal survival in DN patients with the C-index value for this nomogram at 0.845 (95% CI: 0.826-0.864). DCA revealed that our nomogram was superior to models based solely upon clinical indicators. Conclusion: A predictive nomogram incorporating clinical and pathological indicators was developed and validated for the prediction of renal survival outcomes in patients with biopsy-confirmed DN. This model will be of value to clinicians, as it can serve as an easy-to-use and reliable tool for physicians to guide patient management based on individualized risk.
引用
收藏
页码:93 / 101
页数:9
相关论文
共 50 条
  • [32] BIOPSY-PROVEN DIABETIC NEPHROPATHY WORSENS RENAL PROGNOSIS IN DIABETIC PATIENT: RESULTS MULTICENTER STUDY BIODIAB-GLOSEN-GEENDIAB
    Bermejo, Sheila
    Gonzalez, Ester
    Martin, Nadia
    Garcia, Rosa
    Linares, Tania
    Poch, Esteban
    Esparza, Noemi
    Diaz-Encarnacion, Montserrat
    Irene, Agraz
    Isabel Navarro, Maruja
    Lopez, Katia
    Ibernon, Meritxell
    Garcia, Nuria
    Lopez, Diana
    Martin-Gomez, Adoracion
    Praga, Manuel
    Galceran, Josep Ma
    Pascual, Julio
    Fulladosa, Xavier
    Soler Romeo, Maria Jose
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [33] Predictors of Mortality in Patients With Biopsy-Proven Cardiac AL Amyloidosis
    Koutroumpakis, Efstratios
    Niku, Adam
    Black, Christopher K.
    Sadaf, Humaira
    Song, Juhee
    Palaskas, Nicolas L.
    Iliescu, Cezar
    Durand, Jean-Bernard
    Deswal, Anita M.
    Buja, Louis M.
    Banchs, Jose
    [J]. CIRCULATION, 2022, 146
  • [34] Comparison of Performance of Equations for Estimated Glomerular Filtration Rate in Chinese Patients with Biopsy-Proven Diabetic Nephropathy
    Wang, Yiting
    Zhang, Junlin
    Teng, Geer
    Wu, Yucheng
    Han, Qianqian
    Li, Hanyu
    Wang, Tingli
    Liu, Fang
    [J]. DISEASE MARKERS, 2019, 2019
  • [35] Clinical versus histological diagnosis of diabetic nephropathy-is renal biopsy required in type 2 diabetic patients with renal disease?
    Biesenbach, G.
    Bodlaj, G.
    Pieringer, H.
    Sedlak, M.
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2011, 104 (09) : 771 - 774
  • [36] THE HISTOLOGICAL CHARACTERISTICS OF PATIENTS WITH BIOPSY-PROVEN NON-ALCOHOLIC STEATOHEPATITIS
    Fu, Yi-Ming
    Ji, Dong
    Lau, George K. K.
    Chen, Guo-Feng
    [J]. HEPATOLOGY, 2019, 70 : 1075A - 1076A
  • [37] Survival in biopsy-proven myocarditis: A long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors
    Magnani, JW
    Danik, HJS
    Dec, GW
    DiSalvo, TG
    [J]. AMERICAN HEART JOURNAL, 2006, 151 (02) : 463 - 470
  • [38] Clinical Biomarkers at Renal Flare Are Associated with Histologic Changes in Repeat Renal Biopsy in Patients with Biopsy-proven Lupus Nephritis
    Kim, Min Jung
    Lee, Hajeong
    Song, Yeong-Wook
    Lee, Eun Bong
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [39] Renal arteriolar hyalinosis, not intimal thickening in large arteries, is associated with cardiovascular events in people with biopsy-proven diabetic nephropathy
    Morimoto, K.
    Matsui, M.
    Samejima, K.
    Kanki, T.
    Nishimoto, M.
    Tanabe, K.
    Murashima, M.
    Eriguchi, M.
    Akai, Y.
    Iwano, M.
    Shiiki, H.
    Yamada, H.
    Kanauchi, M.
    Dohi, K.
    Tsuruya, K.
    Saito, Y.
    [J]. DIABETIC MEDICINE, 2020, 37 (12) : 2143 - 2152
  • [40] Biopsy-proven acute phosphate nephropathy: A case report
    Medina-Liabres, Kristianne Rachel Palanca
    Kim, Bo Mi
    Kim, Sejoong
    [J]. WORLD JOURNAL OF CLINICAL CASES, 2020, 8 (12) : 2585 - 2589